Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

quantadt.com

Founded Year

2008

Stage

Series D | Alive

Total Raised

$350.52M

Last Raised

$245M | 1 yr ago

About Quanta Dialysis Technology

Quanta has developed advanced hemodialysis systems for use in the home and clinic. The proprietary cartridge-based system SC+ is a compact hemodialysis system providing clinical efficacy utilizing flow rates typically used on traditional machines.

Quanta Dialysis Technology Headquarters Location

Tything Road

Alcester, England, B49 6EU,

United Kingdom

+44 (0) 1789 400043

ESPs containing Quanta Dialysis Technology

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Healthcare Providers Tech

These companies are focused on providing IV therapies and dialysis care at home as opposed to in the office or at an infusion center.

Quanta Dialysis Technology named as Challenger among 8 other companies, including Cricket Health, Somatus, and Monogram Health.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Quanta Dialysis Technology

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Quanta Dialysis Technology in 1 CB Insights research brief, most recently on Mar 12, 2020.

Expert Collections containing Quanta Dialysis Technology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Quanta Dialysis Technology is included in 4 Expert Collections, including Medical Devices.

M

Medical Devices

11,581 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,430 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,351 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

7,901 items

Quanta Dialysis Technology Patents

Quanta Dialysis Technology has filed 21 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/28/2013

3/30/2021

Fluid dynamics, Renal dialysis, Membrane technology, Nephrology, Kidney diseases

Grant

Application Date

1/28/2013

Grant Date

3/30/2021

Title

Related Topics

Fluid dynamics, Renal dialysis, Membrane technology, Nephrology, Kidney diseases

Status

Grant

Latest Quanta Dialysis Technology News

11:30 EDT Global Dialysis Devices Market to Progress at a Substantial CAGR of 4.84% Reaching USD 94.30 billion by 2026, Asserts ...

Apr 19, 2022

News provided by Share this article Share this article The demand for Dialysis Devices is witnessing a surge majorly due to the rising prevalence of kidney failure due to various reasons such as the rising geriatric population wherein age acts as a major risk factor for loss of kidney function leading to a surge in the Dialysis Devices market. Furthermore, the rising prevalence of diabetes and hypertension are the key factors which are extensively linked with kidney failure acting as a major influential factor in boosting the growth of the Dialysis Devices market. LAS VEGAS, April 19, 2022 /PRNewswire/ -- DelveInsight's  Dialysis Market Insights and Forecast  report provides the current and forecastDialysis Market, upcoming innovations in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Dialysis Market. Some of the essential takeaways from the Dialysis Market report :  As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth in the Dialysis market. Some of the Global Dialysis Device companies with dialysis access devices in various stages of development include Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, Cantel Medical Corporation, NIKKISO CO., LTD, Asahi Kasei Medical, NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd., Dialco Medical Inc., SWS Hemodialysis Care Co., Ltd, TORAY MEDICAL CO, LTD., Trivitron Healthcare,  BLT Biolight Meditech, QUANTA Dialysis Technologies, and others. DelveInsight analysis states that the Global Dialysis Market was valued at USD 71.00 Billion in 2020, growing at a CAGR of 4.84% during the forecast period from 2021 to 2026 to reach USD 94.30 Billion by 2026. In March 2021, Baxter Healthcare Corporation received regulatory approval from the US Food and Drug Administration for their AK 98 Dialysis Machine, classified as a Class II medical device. In January 2021, the US Food and Drug Administration granted regulatory approval to Quanta Dialysis Technologies Ltd for their product- the hemodialysis system SC+. The device is a portable system that is capable of offering dialysis care comparable to full-sized dialysis equipment in a range of care settings. In August 2020, the US FDA granted the emergency-use authorization (EUA) for REGIOCIT which is intended to be used as a replacement solution specifically in adult patients who are being treated with CRRT and for whom regional citrate anticoagulation is considered appropriate. In October 2018, Baxter received the CE mark approval for the next-generation continuous renal replacement therapy using the PrisMax system. To pick on the latest highlights related to the Dialysis implantable device market, get a snapshot of the key highlights entailed in the Dialysis Market Sample Report Dialysis Devices Overview  Dialysis Devices are medical equipment and consumables that help in substituting for kidney function in events of kidney failure or compromised kidney function to compensate and remove toxins from the body. The Dialysis access devices is made up of a series of membranes that act as filters and a special liquid called dialysate. The membranes filter waste products from the blood, which are then passed into the dialysate fluid. This Dialysis Device/machine itself can be thought of as an artificial kidney. Geographically, the Global Dialysis market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue North America currently hols the Global Dialysis market share and is expected to remain constant during the forecast period. This domination is owing is due to the rising prevalence of kidney disorders, the rising population of patients suffering from lifestyle disorders such as obesity and hypertension leading to a high surge in Dialysis Devices market growth. Moreover, extensive efforts in product developmental activities and the growing popularity of home-based dialysis devices are further expected to drive the Dialysis Devices market in the North American region. In addition to the above-stated factors, the product development activities, product approvals, and the extensive coverage of procedural costs specifically in the United States and Canada are expected to further boost the Dialysis Devices market in the coming years. For instance, in March 2021, Baxter Healthcare Corporation received regulatory approval from the US Food and Drug Administration for their AK 98 Dialysis Machine, classified as a Class II medical device. Click here to understand more about the key players in the Dialysis Market and their future @ Dialysis Future Assessment The rise in demand for Dialysis Devices is primarily attributed to the rising prevalence of kidney failure due to various reasons such as the rising geriatric population wherein age acts as a major risk factor for loss of kidney function leading to growth in the Dialysis Devices market. Also, the rising prevalence of diabetes in which hyperglycemia is linked with blood vessel damage in the kidneys, and hypertension are the key factors that are extensively linked with kidney failure directly increasing the Dialysis Devices market. Additionally, technological advancements such as the development of continuous renal replacement therapy (CRRT) have also been a major influential factor in boosting the growth of the Dialysis Devices market in the coming years. However, on the contrary, certain factors such as procedure-related complications and the high cost of Dialysis services for patients in growing economies may be growth-restraining factors for the Dialysis Devices market. Moreover, the COVID-19 pandemic had a profound impact on elective and non-urgent surgeries across the countries. The Dialysis Devices market is primarily affected by the outbreak of the COVID-19 pandemic. The government imposed lockdowns to curb the spread of the virus leading to restrictions on movement and a decrease in regular check-ups leading to a decrease in the Dialysis Devices market growth. To gain a better understanding of the COVID-19 impact on Dialysis, get a snapshot of the  COVID-19 Impact on the Dialysis Market Coverage: Global Study Period: 2021-2026 Market Segmentation By Product Type - Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines, And Consumables Market Segmentation By Mobility - Stationary Dialysis Device, And Portable Dialysis Device Market Segmentation By End-User- Hospitals, Dialysis Centers, And Homecare Settings Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of the   World Key Dialysis Companies -  Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, Cantel Medical Corporation, NIKKISO CO., LTD, Asahi Kasei Medical, NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd., Dialco Medical Inc., SWS Hemodialysis Care Co., Ltd, TORAY MEDICAL CO, LTD., Trivitron Healthcare,  BLT Biolight Meditech, QUANTA Dialysis Technologies Porter's Five Forces Analysis Related Reports Chronic Kidney Disease Pipeline Insight, 2022 report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key Chronic Kidney Disease companies involved such as Bayer, AstraZeneca, Celgene, Ipsen, among others. The Global Peritoneal Dialysis Equipment market was valued at USD 4.12 billion in 2020, growing at a CAGR of 5.89 % during the forecast period from 2021 to 2026, to reach USD 5.81 billion by 2026. The report delivers an in-depth understanding of Peritoneal Dialysis Equipment market trends, drivers and barriers, and key Peritoneal Dialysis Equipment companies involved such as Baxter, Fresenius Medical Care AG & Co. KGaA, Terumo Corporation, Medtronic, Utah Medical Products, Polymedicure, Cook, Cardiomed, Angiplast, and others. Acute Kidney Injury Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Acute Kidney Injury companies involved such as Alloksys, Vifor Pharma, Exponential Biotherapies, Astellas Pharma, Pharming Technologies, among others. Anemia in Chronic Kidney Disease Pipeline Insight, 2022 report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key Anemia in Chronic Kidney Disease companies involved such as Pieris Pharmaceuticals, Jiangsu HengRui Medicine, Shenyang Sunshine Pharmaceutical, Biocad, among others. Polycystic Kidney Disease Pipeline Insight, 2022 report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key Anemia in Polycystic Kidney Disease companies involved such as Abbott, Reata Pharmaceuticals, XORTX Therapeutics, Sanofi Genzyme, among others. Kidney Transplant Rejection Pipeline Insight, 2022 report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the key Anemia in Kidney Transplant Rejection companies involved such as Medeor Therapeutics, Talaris Therapeutics, CSL Behring, Novartis, among others. Interested to know more about the breakthrough happenings? Take a look at the posts below  MedTech Industry  Roars Back as FDA Approvals Soar

Quanta Dialysis Technology Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Quanta Dialysis Technology Rank

  • When was Quanta Dialysis Technology founded?

    Quanta Dialysis Technology was founded in 2008.

  • Where is Quanta Dialysis Technology's headquarters?

    Quanta Dialysis Technology's headquarters is located at Tything Road, Alcester.

  • What is Quanta Dialysis Technology's latest funding round?

    Quanta Dialysis Technology's latest funding round is Series D.

  • How much did Quanta Dialysis Technology raise?

    Quanta Dialysis Technology raised a total of $350.52M.

  • Who are the investors of Quanta Dialysis Technology?

    Investors of Quanta Dialysis Technology include Wellington Partners, Seroba Life Sciences, btov Partners, Millennium Management, Novo Holdings and 17 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.